LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 11 of 15: Mean cell count and mean normalized growth rate inhibition values across biological replicate 1. - Dataset (ID:20248)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|
Hs 578T | WYE-125132 | 0.12 | uM | LJP6 | 72 | hr | 929 | 1340 | 3216 | 0.4164 | 0.2259 |
Hs 578T | WYE-125132 | 0.37 | uM | LJP6 | 72 | hr | 929 | 1338 | 3216 | 0.4160 | 0.2252 |
Hs 578T | WYE-125132 | 1.11 | uM | LJP6 | 72 | hr | 929 | 1280 | 3216 | 0.3980 | 0.1955 |
Hs 578T | WYE-125132 | 3.33 | uM | LJP6 | 72 | hr | 929 | 1331 | 3216 | 0.4138 | 0.2219 |
Hs 578T | WYE-125132 | 10 | uM | LJP6 | 72 | hr | 929 | 1265 | 3216 | 0.3933 | 0.1880 |
Hs 578T | Barasertib | 0.04 | uM | LJP5 | 72 | hr | 929 | 1898 | 3237 | 0.5861 | 0.4859 |
Hs 578T | Barasertib | 0.12 | uM | LJP5 | 72 | hr | 929 | 1883 | 3237 | 0.5817 | 0.4799 |
Hs 578T | Barasertib | 0.37 | uM | LJP5 | 72 | hr | 929 | 1917 | 3237 | 0.5924 | 0.4954 |
Hs 578T | Barasertib | 1.11 | uM | LJP5 | 72 | hr | 929 | 1851 | 3237 | 0.5717 | 0.4660 |
Hs 578T | Barasertib | 3.33 | uM | LJP5 | 72 | hr | 929 | 1684 | 3237 | 0.5205 | 0.3916 |
Hs 578T | Barasertib | 10 | uM | LJP5 | 72 | hr | 929 | 1442 | 3237 | 0.4457 | 0.2762 |
Hs 578T | Vemurafenib | 0.04 | uM | LJP5 | 72 | hr | 929 | 3317 | 3237 | 1.0246 | 1.0272 |
Hs 578T | Vemurafenib | 0.12 | uM | LJP5 | 72 | hr | 929 | 3356 | 3237 | 1.0368 | 1.0407 |
Hs 578T | Vemurafenib | 0.37 | uM | LJP5 | 72 | hr | 929 | 3434 | 3237 | 1.0612 | 1.0671 |
Hs 578T | Vemurafenib | 1.11 | uM | LJP5 | 72 | hr | 929 | 3362 | 3237 | 1.0388 | 1.0428 |
Hs 578T | Vemurafenib | 3.33 | uM | LJP5 | 72 | hr | 929 | 2962 | 3237 | 0.9151 | 0.9038 |
Hs 578T | Vemurafenib | 10 | uM | LJP5 | 72 | hr | 929 | 2051 | 3237 | 0.6337 | 0.5523 |
Hs 578T | Enzastaurin | 0.04 | uM | LJP5 | 72 | hr | 929 | 3281 | 3237 | 1.0137 | 1.0151 |
Hs 578T | Enzastaurin | 0.12 | uM | LJP5 | 72 | hr | 929 | 3263 | 3237 | 1.0082 | 1.0091 |
Hs 578T | Enzastaurin | 0.37 | uM | LJP5 | 72 | hr | 929 | 3269 | 3237 | 1.0102 | 1.0113 |
Hs 578T | Enzastaurin | 1.11 | uM | LJP5 | 72 | hr | 929 | 3280 | 3237 | 1.0134 | 1.0150 |
Hs 578T | Enzastaurin | 3.33 | uM | LJP5 | 72 | hr | 929 | 3229 | 3237 | 0.9976 | 0.9971 |
Hs 578T | Enzastaurin | 10 | uM | LJP5 | 72 | hr | 929 | 3070 | 3237 | 0.9484 | 0.9420 |
Hs 578T | Palbociclib | 0.04 | uM | LJP6 | 72 | hr | 929 | 2313 | 3216 | 0.7191 | 0.6638 |
Hs 578T | Palbociclib | 0.12 | uM | LJP6 | 72 | hr | 929 | 2019 | 3216 | 0.6278 | 0.5423 |